Диссертация (1140912), страница 22
Текст из файла (страница 22)
Sato, E. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a highCD8+/reguregulatory T cell ratio are associated with favorable prognosi in ovariancancer / E. Sato, O.S., J. Ahn et al. // Proc Natl Acad Sci USA. – 2005. – N102. – P.18538-18543.125. Sautès-Fridman, C. Tumor microenvironment is multifaceted / C. SautèsFridman, C.-V. J., D. Damotte, S. Fisson, Fridman and C. I. WH, M.C. Dieu-Nosjean// Cancer Metastasis Revz. – 2011. – N30. – P.
13-25.126. Sears, J.D. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer / J.D. Sears, K.G., H.M. Hoen et al. // Cancer. –1994. – N74. – P. 1303-1308.119127. Sheikh, N.A. CD54 is a surrogate marker of antigen presenting cell activation / N.A. Sheikh, J. L. // Cancer Immunol Immunother. – 2008. – N57 (9). – P.1381-1390.128. Smith, H.O. The rising incidence of adenocarcinoma relative to squamouscell carcinoma of the uterine cervix in the United States-a 24-year population-basedstudy / H.O.
Smith, T.M., C.R. Qualls, C.R. Key // Gynecol Oncol. – 2000. – N78. – P.97–105.129. Spaggiari, G.M. Soluble HLA class I induces NK cell apoptosis upon theengagement of killer-activating HLA class I receptors through FasL-Fas interaction /G.M. Spaggiari, P.Contini, A. Dondero et al. // Blood. – 2002. – Vol.100. – P. 40984107.130. Stanley, M. HPV: immune response to infection and vaccination / M.Stanley // Infect Agent Canc. 2010. – N5. – 19 p.131. Stevenson, F.K. Analysis of soluble HLA class II antigenic material inpatients with immunological diseases using monoclonal antibodies / F.K. Stevenson //J.
Immunol. Methods. – 1986. – N86 (2). – P. 187–190.132. Susini, T. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer / T. Susini, F.B., C.M. Howard et al.// J. Clin. Oncol. – 1998. – N16. – P. 1085-1093.133. Susini, T. Expression of the retinoblastoma-related gene Rb2/p130 isdownregulated in atypical endometrial hyperplasia and adenocarcinoma / T. Susini,D.M., M Paglierani et al.
// Hum. Pathol. – 2001. – N32. – P. 360-367.134. Takeda, N. Mutivariate analysis of histopathologic prognostic factors forinvasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy / N. Takeda, S. N., M. Takeda et al // Acta Obstet GynecolScand. – 2002. – N81. – P.
1144-1151.135. Tamakoshi, A. Soluble Fas level and cancer mortality: findings from anested case-control study within a large-scale prospective study / A. Tamakoshi, N. K.,Y. Ito, Y. Lin, K. Yagyu, S. Kikuchi, Y. Watanabe, Y. Inaba, K. Tajima K; Japan Collaborative Cohort Study Group // Int J Cancer.
– 2008. – P.1913-1916120136. Tesarová, P. Soluble adhesion molecules in female patients with breastcarcinoma / P. Tesarová, K. J., A. Umlaufová, J. Homolková, M. Kalousová, V. Tesar// Cas Lek Cesk. – 2003. – N142 (5). – P. 292-299.137.Topalian, SL. Safety, activity, and immune correlates of anti-PD-1 anti-body in cancer/ SL. Topalian, FS .Hodi, JR .Brahmer, SN .Gettinger, DC .Smith, DF.McDermott, et al.
// N Engl J Med 012; 366:2443-54.138. Ugurel, S. Increased soluble CD95 (sFas/CD95) serum level correlateswith poor prognosis in melanoma patients / S. Ugurel, G. Rappl, W. Tilgen, U.Reinhold // Clin. Cancer Res. – 2001. – N7.139. van Buul, J.D. ICAM-3 activation modulates cell-cell contacts of humanbone marrow endothelial cells / J.D. van Buul J.D., F. P. M., C.E. van der Schoot, P.L.Hordijk // J. Vasc. Res. – 2004. – N41. – P. 28–37.140. van Driel, W.J. Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma/ W.J. van Driel, T.M., C.
Hilders, B.Trimbos, G.J. Fleuren // Gynecol Oncol. – 1996. – N62. – P. 33-41.141. Vavra, N. Prognostic factors related to recurrent endometrial carcinomafollowing initial surgery / N. Vavra, U.D., M. Kucera et al. // Acta Obstet. Gynecol.Scand. – 1993. – N72. – P. 205-209.142.
Velikova , G. Circulating soluble adhesion molecules E-cadherin, Eselectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer / G. Velikova, B. R., A. Gearing, I.Hemingway, M.A. Forbes, S.R. Preston, M. Jones, J. Wyatt, K.
Miller, U. Ward, J. AlMaskatti, S.M. Singh, N.S. Ambrose, J.N. Primrose, P.J. Selby // Br J Cancer. – 1997.– N76 (11). – P. 1398-1404.143. Verbuggen, L.A. Soluble HLA–DR antigen levels in serum correlate withrheumatoid arthritis disease activity and the presence of disease–associated epitopes /L.A. Verbuggen // Tissue Antigens. – 2000.
– N56 (5). – P. 436–440.144. Verkarre, V. ICAM-3 and E-selectin endothelial cell expression differentiate two phases of angiogenesis in infantile hemangiomas / V. Verkarre, N. P.-M., R.121de Serre, D. Vazeux, B. Teillac-Hamel, C. Chretien-Marquet, M. Le Bihan, S. Leborgne, N. Fraitag, N. Brousse // J. Cutan. Pathol. – 1999. – N26. P. 17–24.145. Wolchok, JD.
Nivolumab plus ipilimumab in advanced melanoma/ JD.Wolchok, H.Kluger, MK.Callahan, MA. Postow, NA .Rizvi, AM .Lesokhin, et al. //NEngl J Med -2013-369:122-33.146. Yang, L. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow / L. Yang, F.R., T.E.Sciuto, A.M. Dvorak, R. Alon, F.W. Luscinskas // Blood. – 2005.
– N106 (2). – P. 84592.147. Yu, P. Tumor-infiltrating T lymphocytes: friends or foes? / P. Yu, F. X. //Lab Invest. – 2006. – N86. – P. 231-245.148. Zavazava, N. Soluble HLA class I molecules induce apoptosis in alloreactive – P. 1005-1008.149. Zhang, L Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer / L. Zhang, JR.Conejo , D. Katsaros et al.
– 2003.150.Zreik, T.G. "Parametrial involvement, regardless of nodal status: apoor prognostic factor for cervical cancer / T.G. Zreik, C. J., S.K. Chambers (1996). //Obstet Gynecol. – 1996. – N87. – P. 741-746..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
